Injury guide

PFAS and Kidney Cancer: Your Next Steps

Had kidney cancer and worry about PFAS? Keep your care and water records.

See If You Qualify

Free · No obligation · About 2 minutes

Updated Oct 4, 202626 sources

This may apply to you if

  • Gather reports for your water source and the dates you used it.
  • Keep diagnosis, treatment and authorized care records.
  • Ask which exposure proof, legal rules and personal time limit apply.

What the public record says

These are cited sources. Their inclusion does not imply that they endorse People’s Justice or reviewed this page.

Joseph J. Shearer · Division of Cancer Epidemiology and Genetics, National Cancer Institute · First-listed co-first author

Finding: The nested case-control study found a positive association between prediagnostic blood PFOA levels and renal cell carcinoma. It did not establish the cause of one person’s illness.

Shearer and colleagues: PFAS and renal cell carcinoma (opens in a new tab) · Sep 18, 2020 · Checked Oct 3, 2026

Jonathan N. Hofmann · Occupational and Environmental Epidemiology Branch, National Cancer Institute · First-listed author of the 2026 cohort update

Finding: The updated high-exposure cohort found associations with kidney and testicular cancers. Thyroid cancer findings varied by group; modeled exposure cannot identify one person’s cause.

Hofmann et al.: updated Mid-Ohio Valley cancer cohort (opens in a new tab) · Jul 10, 2026 · Checked Oct 3, 2026

The evidence and its limits

National Cancer Institute with collaborating CDC and Harvard researchers · Journal of the National Cancer Institute · 2021

Prediagnostic PFAS and renal cell carcinoma in PLCO

Design:
Case-control
Participants:
324 renal cell carcinoma cases and 324 matched controls with prediagnostic blood samples.
Finding:
Higher blood PFOA was positively associated with renal cell carcinoma.
Main limitation
Observational nested case-control analysis; no assigned PFAS exposure or proof of local water source or individual causation.

Read the source: Prediagnostic PFAS and renal cell carcinoma in PLCO (opens in a new tab) · Checked Oct 3, 2026

National Cancer Institute and collaborating Multiethnic Cohort researchers · Environment International · 2023

PFAS and renal cell carcinoma in the Multiethnic Cohort

Design:
Case-control
Participants:
428 renal cell carcinoma cases and 428 matched controls with prediagnostic blood samples.
Finding:
PFOA was not associated with renal cell carcinoma overall; some subgroup findings were suggestive.
Main limitation
Observational analysis of specific chemicals and groups; an overall null association does not prove zero personal risk, nor do subgroup findings establish one person’s cause.

Read the source: PFAS and renal cell carcinoma in the Multiethnic Cohort (opens in a new tab) · Checked Oct 3, 2026

National Cancer Institute and collaborating Emory researchers · Environment International · 2026

Updated Mid-Ohio Valley PFOA cancer cohort

Design:
Cohort
Participants:
32,050 participants:28,398 community members and 3,652 workers
Finding:
Positive kidney/testicular cancer associations; thyroid findings especially in women and more exposed workers.
Main limitation
Observational high-exposure cohort with modeled past exposure. No assigned exposure or proof of an individual’s source.

Read the source: Updated Mid-Ohio Valley PFOA cancer cohort (opens in a new tab) · Checked Oct 3, 2026

The short answer

What is renal cell cancer?
It is cancer in small tubes inside the kidney. Other cancers can start in nearby parts. Ask which type your records name. [24]
What signs should I discuss with a doctor?
Blood in urine or a lasting pain in your side needs a doctor’s check. Some kidney cancers have no early signs. Those signs can also have other causes. [24]
How is it diagnosed and treated?
Doctors use your history, an exam and tests. Scans can help; a tissue sample is not always needed. Care depends on the cancer and your health. [24]
What does the research say?
Some studies found a link with PFOA, one PFAS chemical. Another found no clear link overall. None proves a water source caused your cancer. [8]

What rules a case out

Not covered by this case

  • A PFAS blood test cannot predict future health problems or give a treatment plan.
  • The 3M public-water-system settlement is not a personal injury payout schedule.

The process

What happens next

  1. 01

    You answer a few questions

    About two minutes. Nothing is sent until you agree on the last step and press submit.

  2. 02

    A lawyer looks at it

    A lawyer at the firm reads your answers and checks them against the current case criteria.

  3. 03

    The firm decides and gets in touch

    If the firm takes your case, you get the terms in writing to read before you sign. You can always say no.

When it fits this case

  • Gather reports for your water source and the dates you used it.
  • Keep diagnosis, treatment and authorized care records.
  • Ask which exposure proof, legal rules and personal time limit apply.

Had kidney cancer and worry about PFAS? Keep your care and water records. Studies can guide questions, but they do not prove what caused your own cancer.

What is renal cell cancer?

It is cancer in small tubes inside the kidney. Other cancers can start in nearby parts. Ask which type your records name.

Renal cell cancer is not every cancer found near the kidney. A report that names the exact cell type helps keep your medical history clear. Use the diagnosis on that report when asking about research or a legal claim.

What signs should I discuss with a doctor?

Blood in urine or a lasting pain in your side needs a doctor’s check. Some kidney cancers have no early signs. Those signs can also have other causes.

The NCI also lists a lump in the belly among possible signs. Symptoms do not identify a PFAS source, and a symptom list cannot diagnose you. Tell your clinician about new symptoms and the water or work history that concerns you.

How is it diagnosed and treated?

Doctors use your history, an exam and tests. Scans can help; a tissue sample is not always needed. Care depends on the cancer and your health.

Your team may review scans, blood or urine results and any tissue report. Ask how far the disease has spread and what that means for care. A legal review does not replace those decisions or give a reason to put care on hold.

What does the research say?

Some studies found a link with PFOA, one PFAS chemical. Another found no clear link overall. None proves a water source caused your cancer.

The earlier study compared 324 kidney-cancer cases with 324 matched controls. The later study compared 428 cases with 428 controls and found no overall PFOA association. A 2026 update of a highly exposed community and worker cohort found positive kidney-cancer associations. Different populations and exposure measures matter when comparing those findings.

Who may qualify for a claim check?

Ask for a review of your diagnosis, places and dates. A blood result alone cannot prove the cause. A lawyer must check the law for your situation.

Write down the water sources you used and when you lived or worked there. Keep actual test notices rather than assuming all nearby homes shared one supply. A research finding and a public-water-system settlement answer different questions from an individual injury claim.

What records help me prepare?

Keep the diagnosis report and care records you have. Add water results and dates at each address. Ask before sharing sensitive files.

You generally can request copies from a covered health provider, with exceptions and permitted copy costs. Record which documents are missing. Before signing with a firm, ask for written fees and case expenses; a fee percentage alone does not describe every deduction.

Find out where you stand.

The review is free and private. Asking for it doesn’t commit you to anything.

Register your interest

Sources

  1. EPA PFAS drinking-water regulationEPA PFAS drinking-water regulation · regulator
  2. EPA proposed PFOA/PFOS compliance extensionEPA proposed PFOA/PFOS compliance extension · regulator
  3. EPA proposed PFAS rescission ruleEPA proposed PFAS rescission rule · regulator
  4. EPA PFAS in private wellsEPA PFAS in private wells · regulator
  5. ATSDR PFAS information for cliniciansATSDR PFAS information for clinicians · regulator
  6. ATSDR testing for PFASATSDR testing for PFAS · regulator
  7. IARC PFOA/PFOS evaluation Q&AIARC PFOA/PFOS evaluation Q&A
  8. Shearer and colleagues: PFAS and renal cell carcinomaShearer and colleagues: PFAS and renal cell carcinoma · study
  9. Rhee and colleagues: PFAS and renal cell carcinoma in Multiethnic CohortRhee and colleagues: PFAS and renal cell carcinoma in Multiethnic Cohort · study
  10. Gergel 3M public water systems final approval orderGergel 3M public water systems final approval order · court
  11. Court-authorized 3M water-system settlement FAQCourt-authorized 3M water-system settlement FAQ · court
  12. ABA Model Rule 1.5 feesABA Model Rule 1.5 fees
  13. HHS your medical recordsHHS your medical records · regulator
  14. SDNY how long do I have to file?SDNY how long do I have to file? · court
  15. EPA Issues $3.125M Consent Decree Against WTG Gas Processingecho.epa.gov · Jun 21, 2026 · regulator
  16. Study Finds PFAS in Kidney Tissue Linked to Doubled Transplant Risk; EPA Issues $1.2M Finepubmed.ncbi.nlm.nih.gov · Jul 9, 2026 · study
  17. Personal-injury track status: by Case Management Order No. 35 (Aug. 15, 2025), Judge Richard M. Gergel vacated the bellwether trial set for October 20, 2025, and all related dates in CMO 26-I, citing a large number of unfiled cases, and opened a 21-day Filing Facilitation Window for personal-injury cases alleging one of the six listed injuries (kidney cancer, testicular cancer, ulcerative colitis, thyroid disease, liver cancer and thyroid cancer). The JPML reported 15,264 actions pending in MDL 2873 on October 1, 2026; that count covers all actions in the MDL.scd.uscourts.gov · Aug 15, 2025 · court
  18. Judge Gergel (D.S.C., AFFF MDL-2873) granted final approval of 3M's public water supplier settlement: $10.3B pre-tax present value, up to $12.5B nominal, paid over 13 years starting Q3 2024, covering U.S. public water suppliers that have detected or may detect PFAS. Verified via 3M's official press release.investors.3m.com · Mar 29, 2024
  19. Chemours, DuPont and Corteva announced a $1.185B settlement fund resolving PFAS drinking-water claims of a defined class of U.S. public water systems (Chemours ~$592M, DuPont ~$400M, Corteva ~$193M), subject to D.S.C. court approval in AFFF MDL-2873; excludes state/federally owned systems and most lower Cape Fear Basin systems. Verified via DuPont's official press release. (Final court approval followed in Feb 2024 per SEC filings — approval date not independently fetched.)dupont.com · Jun 2, 2023
  20. EPA Levies $1.26M Federal Penalty Against Hasa, Inc.echo.epa.gov · Jul 4, 2026 · regulator
  21. EPA Enforcement Record Shows $541,110 Penalty Tied to AMVAC Facilityecho.epa.gov · Jul 24, 2026 · regulator
  22. EPA Issues $995,000 Penalty Against Brenntag Great Lakesecho.epa.gov · Aug 2, 2026 · regulator
  23. EPA Lists $930,000 Penalty Against Colgate-Palmoliveecho.epa.gov · Sep 10, 2026 · regulator
  24. NCI: renal cell cancer patient guidance
  25. Hofmann et al.: updated Mid-Ohio Valley cancer cohortHofmann et al.: updated Mid-Ohio Valley cancer cohort · study
  26. VA: PFAS during military serviceVA: PFAS during military service · regulator

Checked against 21 primary sources by People's Justice editors · Updated

How we make money

People's Justice research team · Updated Oct 4, 2026